Taken together, these findings suggest that knocking down APOC1 can promote apoptosis in DLBCL cells and reduce their proliferation, migration, invasion, angiogenesis, and tumor growth via the PI3K/AKT/mTOR signaling pathway. Here, MTOR is linked to diffuse large B-cell lymphoma.